MRL Ventures Fund Investor
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
Funding Status:
Series A
Estimated Revenue:
$1M to $10M
Total Funding:
18735034
Industry:
Biomarkers Discovery
Employee Number:
1-10
Investment Stage:
Convertible Note, Early Stage Venture, Seed, Venture
Last Funding Date:
2018-05-23
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2014-01-01
Last Funding Type:
Series A
Number Of Exists:
11
Investor Type:
Corporate Venture Capital, Venture Capital